1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


TABLE 3: 
Number of detected tumors (mean for observers 1 and 2) in relation to tumor size for each MR imaging technique as compared with criterion standard DSA
0–10 mm11–20 mm21–30 mm31–50 mm≥51 mm
T2W-FSE1 (0)11 (3)10 (2)22 (17)8 (8)
T2W-FS-FSE1 (0)9 (2)11 (3)21 (17)8 (7)
CE-T1 W-FS-SE1 (0)11 (2)10 (0)22 (16)8 (8)
CE-3D TOF3 (1)17 (11)12 (10)22 (20)8 (8)
DSA91912228
  • Note.—T2W-FSE indicates dual T2-weighted fast spin-echo; T2W-FS-FSE, T2-weighted fat-suppressed fast spin-echo; CE-T1 W-FS-SE, contrast-enhanced T1-weighted fat-suppressed spin-echo; 3D TOF MRA, unenhanced and contrast-enhanced 3D time-of-flight MR angiography; DSA, digital subtraction angiography. Data in parenthesis represent presence of intra-tumoral flow for each subgroup and technique.